OPKO Health, Inc. (OPK)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$1.64+1.86%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · OPK
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 587.9 | 606.9 | 713.1 | 863.5 | 1,004.2 | 1,774.7 | 1,435.4 | 901.9 | 990.3 | 966.0 | 1,117.5 | 447.5 | 91.1 | 96.5 | 47.0 | 28.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 966.0 | 1,117.5 | 447.5 | 91.1 | 96.5 | 47.0 | 28.0 |
| Cost of Revenues | 348.2 | 400.9 | 494.6 | 545.4 | 716.0 | — | — | — | — | — | 564.1 | 193.3 | 9.4 | 10.4 | 27.9 | 17.2 |
| Gross Profit | 239.7 | 205.9 | 218.5 | 318.1 | 288.2 | — | — | — | — | — | — | — | — | — | 19.2 | 10.7 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 205.9 | 223.0 | 304.2 | 300.6 | 372.7 | 468.9 | 355.6 | 343.3 | 358.3 | 414.6 | 407.3 | 172.1 | 57.9 | 55.3 | 27.8 | 19.2 |
| R&D Expenses | 125.2 | 124.0 | 105.2 | 89.6 | 73.9 | 76.9 | 75.3 | 117.9 | 125.6 | 126.4 | 113.9 | 101.8 | 83.6 | 53.9 | 19.5 | 11.4 |
| Operating Income | (48.2) | (117.4) | (152.1) | (157.0) | (226.3) | 18.8 | 57.7 | (274.1) | (171.2) | (276.4) | (96.6) | (120.6) | (145.8) | (79.6) | (37.3) | (23.2) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 108.5 | 47.5 | 13.5 | 12.1 | 18.9 | — | — | — | — | — | — | — | — | — | 1.0 |
| Interest & Investment Income | 13.1 | 14.8 | 8.4 | 4.0 | 2.0 | 0.0 | — | — | — | — | — | — | — | — | — | 0.3 |
| Net Interest Expenses | — | — | — | 9.5 | 10.1 | 18.9 | — | — | — | — | — | — | — | — | — | 0.7 |
| Other Non-Operating Income / Expenses | (31.6) | (124.0) | 141.7 | (27.3) | (165.3) | (32.8) | (9.0) | (30.9) | (6.1) | 4.5 | (0.3) | (39.5) | (25.2) | (24.6) | — | — |
| Asset Writedown | — | — | — | — | 0.0 | 0.0 | 0.0 | 92.4 | 21.8 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (79.8) | (241.4) | (10.4) | (184.3) | (391.5) | (14.0) | 48.7 | (305.0) | (177.3) | (271.9) | (96.8) | (160.1) | (171.0) | (104.2) | (37.1) | (24.2) |
| Income Tax Expense | (7.0) | (15.7) | 42.8 | 4.4 | (63.5) | 15.5 | 17.6 | 7.1 | (38.7) | 18.9 | (56.1) | (113.7) | 0.0 | 1.7 | (9.6) | (19.4) |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | — | — | (117.3) | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | (1.4) | (3.0) | (2.9) | (0.5) | — |
| Net Income | (72.9) | (225.7) | (53.2) | (188,863.0) | (328,405.0) | (30,143.0) | 30.6 | (314.9) | (153.0) | (305.3) | (48.4) | (52.1) | (171.7) | (114.4) | (29.0) | (1.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.10) | (0.30) | (0.08) | (0.25) | (0.46) | (0.05) | 0.05 | (0.53) | (0.27) | — | — | — | — | — | — | (0.01) |
| Diluted EPS | (0.10) | (0.30) | — | (0.25) | (0.46) | (0.05) | 0.05 | — | (0.27) | — | — | — | — | — | — | — |
| Revenue per Share | 0.78 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 755.3 | 751.1 | 694.0 | 751.8 | 719.1 | 648.1 | 640.7 | — | 563.1 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 755.3 | 751.1 | — | 751.8 | 719.1 | 648.1 | 640.7 | — | 563.1 | — | — | — | — | — | — | 280.7 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (25.8) | (53.9) | (51.7) | (117.6) | 97.5 | 143.1 | (180.2) | (73.9) | (174.3) | 0.0 | (78.3) | (130.9) | (64.4) | (27.1) | (19.4) |
| EBIT | (48.2) | (117.4) | (152.1) | (157.0) | (226.3) | 18.8 | 57.7 | (274.1) | (171.2) | (276.4) | (96.6) | (120.6) | (145.8) | (79.6) | (37.3) | (23.2) |
| Effective Tax Rate | 8.7% | — | — | -2.4% | 16.2% | -110.4% | 36.2% | -2.3% | 21.8% | -6.9% | 58.0% | 71.0% | -0.0% | -1.6% | 25.9% | 79.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.